Home › Funds › Madison Avenue Partners, LP › GMED

Madison Avenue Partners, LP position in GMED

GLOBUS MED INC · Health Care

Madison Avenue Partners, LP reported holding 936,540 shares of GMED (GLOBUS MED INC) in its Q3 2026 13F filing — a position valued at US$70.1M, representing 2.78% of its reported portfolio and ranking #14 among its reported holdings. Madison Avenue Partners, LP has disclosed GMED holdings in 9 of the last 11 reported quarters, going back to Q1 2024.

Latest position (Q3 2026)936.54K sh
Reported value held$70.15M
Portfolio Weight2.78%
First reportedQ1 2024
Last changeHold
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Madison Avenue Partners, LP's GMED position evolved

Madison Avenue Partners, LP first disclosed a stake in GMED in Q1 2024 at 703,276 shares (US$37.7M). The position peaked in Q4 2025 at 2,624,751 shares, worth US$229.2M. Across 9 filings, Madison Avenue Partners, LP increased the stake 4 time(s), trimmed it 2 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 936,540 shares valued at US$70.1M. Notable position changes include a 101% increase in Q2 2024 (shares rose 4% over the following quarter), a 49% increase in Q3 2025 (shares rose 52% over the following quarter), a 73% trim in Q1 2026 (shares fell 8% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2024 703.28K $37.72M New
Q2 2024 1.42M $96.99M Add
Q3 2024 1.14M $81.34M Reduce
Q2 2025 1.71M $101.05M New
Q3 2025 2.55M $145.93M Add
Q4 2025 2.62M $229.17M Add
Q1 2026 717.48K $61.82M Reduce
Q2 2026 935.22K $73.89M Add
Q3 2026 936.54K $70.15M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About GMED and 13F data

GMED (GLOBUS MED INC) is a Health Care company. 36 other funds we track also report a position in GMED — the largest reported positions include KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC (US$239.4M), Boston Trust Walden Corp (US$123.1M), GW&K Investment Management, LLC (US$110.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding GMED

All GMED fund holders →

FAQ

How long has Madison Avenue Partners, LP held GMED?

Madison Avenue Partners, LP has disclosed GMED holdings in 9 of the last 11 reported quarters, going back to Q1 2024.

What is Madison Avenue Partners, LP's current position in GMED?

As of Q3 2026, Madison Avenue Partners, LP holds 936.54K shares of GMED (GLOBUS MED INC), valued at $70.15M, representing 2.78% of its reported portfolio and ranking #14.

Has Madison Avenue Partners, LP been buying or selling GMED?

In the latest 13F filing (Q3 2026), Madison Avenue Partners, LP held unchanged its position in GMED. The position peaked in Q4 2025 at 2.62M shares.

Which other funds hold GMED?

Other major institutional holders of GMED include KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC, Boston Trust Walden Corp, GW&K Investment Management, LLC, among 36 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.